New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For JNJ;JCP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 26, 2014
06:26 EDTJCPEarly retail estimates show best holiday sales in three years, WSJ says
A report from yesterday afternoon explained that early estimates show the biggest increase in holiday shopping sales in the last three years, reports the Wall Street Journal, citing the International Council of Shopping Centers. Sales could have come at the expense of profits due to promotions, the Journal added. Publicly traded companies in the space include Best Buy (BBY), Costco (COST), Target (TGT) and Wal-Mart (WMT), J.C. Penney (JCP), Kohl's (KSS), Macy's (M), Nordstrom (JWN) and Sears (SHLD). Reference Link
December 22, 2014
08:01 EDTJNJAASLD publishes new recommendations for treating Hepatitis C
Subscribe for More Information
06:33 EDTJNJSevion announces antibody discovery collaboration with Johnson & Johnson
Subscribe for More Information
06:29 EDTJNJGilead drops 4% after Express Scripts picks AbbVie for hepatitis C
Shares of Gilead (GILD) are moving lower in pre-market trading after Express Scripts (ESRX) spokesman Brian Henry told CNBC's Meg Tirrell and other news outlets that the pharmacy benefits manger will exclusively offer AbbVie's (ABBV) recently approved hepatitis C regimen Viekira Pak at a "significant discount" starting Jan. 1. Express Scripts will no longer offer competing drugs from Gilead and Johnson & Johnson (JNJ). Shares of AbbVie are rising 6% to $71.50 in pre-market trading while Gilead is down 4% to $104.15. AbbVie discovered part of the Viekira Pak regimen via its ongoing collaboration with Enanta Pharmaceuticals (ENTA). Shares of Enanta are up 7% to $49.96 in pre-open trading.
06:05 EDTJNJMacroGenics ennters collaboration, license agreement with Janssen
Subscribe for More Information
05:44 EDTJNJExpress Scripts to offer AbbVie hepatitis C drug exclusively, CNBC reports
Express Scripts (ESRX) will offer AbbVie's (ABBV) just approved hepatitis C regimen Viekira Pak at a "significant discount" starting Jan. 1, while excluding competing drugs from Gilead (GILD) and Johnson & Johnson (JNJ), CNBC's Meg Tirrell reports, citing comments from the pharmacy benefits manager's spokesman Brian Henry. Reference Link
December 19, 2014
11:08 EDTJNJJohnson & Johnson receives positive CHMP opinion to extend Velcade indication
Subscribe for More Information
09:37 EDTJCPActive equity options trading
Active equity options trading according to Track Data: AAPL TSLA BBRY AMZN CELG GILD JCP AMAT FB
December 17, 2014
09:04 EDTJNJHalozyme enters collaboration pact with Janssen for ENHANZE Technology
Subscribe for More Information
09:02 EDTJNJHalozyme enters collaboration pact with Janssen for ENHANZE Technology
Subscribe for More Information
08:06 EDTJNJInovio appoints Zane Yang as VP, Clinical Development, Oncology
Subscribe for More Information
December 16, 2014
07:20 EDTJNJGeron announces early HSR clearance for collaboration with Janssen
Subscribe for More Information
December 15, 2014
09:38 EDTJCPActive equity options trading
Subscribe for More Information
December 12, 2014
14:01 EDTJNJGenOn Energy to receive $3M milestone payment in Janssen collaboration
Genmab announced it has reached a milestone in its DuoBody technology platform collaboration with Janssen Biotech (JNJ), triggering a $3M payment. The milestone payment is for pre-clinical progress with a DuoBody product candidate targeting cancer. Today's news will not impact Genmab's 2014 financial guidance.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use